CorMedix, Inc. (CRMD)
7.86
-0.24
(-2.96%)
USD |
NASDAQ |
Oct 23, 16:00
7.86
0.00 (0.00%)
After-Hours: 17:48
CorMedix Market Cap : 610.46M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 629.10M |
| October 21, 2026 | 605.03M |
| October 20, 2026 | 587.94M |
| October 19, 2026 | 573.18M |
| October 16, 2026 | 563.86M |
| October 15, 2026 | 579.40M |
| October 14, 2026 | 573.96M |
| October 13, 2026 | 573.96M |
| October 12, 2026 | 579.40M |
| October 09, 2026 | 573.18M |
| October 08, 2026 | 568.52M |
| October 07, 2026 | 565.42M |
| October 06, 2026 | 565.42M |
| October 05, 2026 | 563.86M |
| October 02, 2026 | 558.43M |
| October 01, 2026 | 576.29M |
| September 30, 2026 | 598.04M |
| September 29, 2026 | 615.90M |
| September 28, 2026 | 612.79M |
| September 25, 2026 | 609.69M |
| September 24, 2026 | 603.47M |
| September 23, 2026 | 597.26M |
| September 22, 2026 | 604.25M |
| September 21, 2026 | 603.47M |
| September 18, 2026 | 599.59M |
| Date | Value |
|---|---|
| September 17, 2026 | 605.03M |
| September 16, 2026 | 607.36M |
| September 15, 2026 | 602.70M |
| September 14, 2026 | 612.79M |
| September 11, 2026 | 607.74M |
| September 10, 2026 | 618.23M |
| September 09, 2026 | 631.43M |
| September 08, 2026 | 635.32M |
| September 04, 2026 | 654.73M |
| September 03, 2026 | 657.84M |
| September 02, 2026 | 668.71M |
| September 01, 2026 | 650.85M |
| August 31, 2026 | 641.53M |
| August 28, 2026 | 644.64M |
| August 27, 2026 | 645.41M |
| August 26, 2026 | 651.63M |
| August 25, 2026 | 664.83M |
| August 24, 2026 | 643.08M |
| August 21, 2026 | 636.87M |
| August 20, 2026 | 639.20M |
| August 19, 2026 | 661.72M |
| August 18, 2026 | 634.54M |
| August 17, 2026 | 595.71M |
| August 14, 2026 | 585.61M |
| August 13, 2026 | 632.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 31.31M |
| Eloxx Pharmaceuticals, Inc. | 51.83M |
| Breakthrough Chemistry, Inc. | 0.9729M |
| BioStem Technologies, Inc. | 28.16M |
| Cardiac Biotech Solutions, Inc. | 5.573M |
Market Cap Related Metrics
| PE Ratio | 3.735 |
| PS Ratio | 1.554 |
| PEG Ratio | 0.0206 |
| Price to Book Value | 1.325 |
| Price to Free Cash Flow | 2.872 |
| Price | 7.86 |
| Earnings Yield | 26.78% |
| PEGY Ratio | 0.0206 |
| Operating PE Ratio | 3.310 |
| Normalized PE Ratio | 3.570 |